Investment brings the patents and manufacturing of UC-II® product in-house
Benicia, CA – InterHealth Nutraceuticals, Inc. (“InterHealth”), a leading researcher, developer and marketer of branded nutraceutical ingredients, todayannounced that it has acquired the assets of Chick Cart Inc. (“Chick Cart”), a Fort Smith Arkansas based manufacturer of nutritional ingredients. Chick Cart is the holder of the primary patents related to the manufacture of undenatured type-II collagen, which hadpreviously been exclusively licensed to InterHealth’s for use in its UC-II® joint health product.
“The acquisition of Chick Cart provides InterHealth with increased control over the supply chain and intellectual property for our UC-II® product line. Chick Cart has built a best in class manufacturing platform and operating team which are a welcome addition to the InterHealth team,” according to Paul Dijkstra, President and CEO of InterHealth.
The transaction marks the first acquisition completed by InterHealth since its acquisition by Kainos Capital in November 2013.
“InterHealth has a portfolio of branded functional ingredients supported by strong clinicaldata.” stated Andrew Rosen, Managing Partner of Kainos Capital. “UC-II® is sold to a global customer base and continues to generate strong growth in the marketplace. This acquisition will better enable InterHealth to invest in additional production capacity to support the growth of UC-II® going forward.” continued Rosen.
“UC-II® is sold to a global customer base and continues to generate strong growth in the marketplace. This acquisition will better enable InterHealth to invest in additional production capacity to support the growth of UC-II® going forward.”
Andrew Rosen
About InterHealth Nutraceuticals, Inc.
InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements andnutraceutical food and beverage products. The company’s products include UC-II® for addressing joint discomfort; Super CitriMax®, a weight loss and satiety ingredient; Meratrim® for weight management; and ChromeMate® and Zychrome® for blood sugar and insulin control. In addition, InterHealth offers LOWAT®, Aller-7®, OptiBerry®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707- 751-2800 (outside U.S.).
Deloitte Corporate Finance LLC Advises Kainos Capital, LLC on its Acquisition of InterHealth Nutraceuticals, Inc.
February 11, 2014
Dallas, TX /PRNewswire/ — Deloitte Corporate Finance LLC (“DCF”) acted as the financial advisor to Kainos Capital, LLC (“Kainos”) in its acquisition of InterHealth Nutraceuticals, Inc. (“InterHealth”).
“DCF’s knowledge and experience in the nutritional supplement industry enabled us to better understand the complex landscape in which InterHealth operates. DCF’s leadership, experience and industry access were vital to accomplishing the transaction,” said Andrew Rosen, Managing Partner of Kainos Capital, LLC.
“DCF’s knowledge and experience in the nutritional supplement industry enabled us to better understand the complex landscape in which InterHealth operates. DCF’s leadership, experience and industry access were vital to accomplishing the transaction.”
Andrew Rosen
“The professionals at Kainos have extensive investment and operational experience in the food and beverage industry and have, in our opinion, identified another exceptional company to add to their portfolio. With the support and leadership of the Kainos team, InterHealth is expected to further penetrate its end markets and continue to strengthen its competitive position,” said Lorin DeMordaunt, managing director, Deloitte Corporate Finance LLC, and head of DCF’s consumer and retail group.
Benicia, CA — InterHealth Nutraceuticals, Inc (“InterHealth”), a leading researcher, developer and marketer of branded nutraceutical ingredients, today announced that it has been acquired by Kainos Capital, LLC, a Dallas-based private equity firm with an exclusive focus on the food and consumer sector. The transaction marks an inflection point in InterHealth’s evolution into becoming a global leader in providing functional specialty ingredients to the dietary supplement, functional food and beverage, pet health and cosmeceutical end markets.
“InterHealth’s success has been marked by its unique, high quality ingredients, extensieve research program, outstanding customer service and powerful co-branding strategy that delivers relevant and differentiated concepts to its customers,” commented Paul Dijkstra, CEO of InterHealth. Dijkstra added, “Kainos brings deep experience in the nutritional ingredient sector which will assist InterHealth through its next phase of growth.”
“InterHealth’s success has been marked by its unique, high quality ingredients, extensieve research program, outstanding customer service and powerful co-branding strategy that delivers relevant and differentiated concepts to its customers.”
Paul Dijkstra
“We believe InterHealth is an outstanding organization, led by a management team with a strong commitment to science-based product development and unwavering quality and customer service,” stated Andrew Rosen, Managing Partner of Kainos Capital. “InterHealth’s portfolio of branded functional ingredients is supported by strong clinical data and addresses functional end markets that have compelling and enduring growth dynamics,” continued Rosen.
“The partnership with Kainos significantly strengthens our ability to supply existing and new customers and should enable us to aggressively expand our portfolio of speciality branded ingredients through strategic partnerships and acquisitions,” added Dijkstra.
C.W. Downer & Co. acted as financial advisor to InterHealth and Delloitte Corporate Finance acted as financial advisor to Kainos.
Read the full story: https://www.bevnet.com/news/supplier-news/2014/kainos-capital-acquires-interhealth-nutraceuticals/
The Dallas Business Journal names our very own Dave Knickel as CFO of the year.
Read the full article: https://www.bizjournals.com/dallas/print-edition/2013/10/25/cfo-of-the-year-dave-knickel-kainos.html